Ms Averil Power:

Regarding new programmes, we need to increase the uptake of existing ones and then look at things like lung cancer, which has a European recommendation now, and at prostate screening, which there is good evidence behind. Many people pay privately for a prostate-specific antigen, PSA, test, but it is not equally available to everybody. Professor Kennedy might have something to add.